|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Cytomegalovirus (CMV) is a herpes virus that causes severe illness and death in people who are immunocompromised, including organ and bone marrow transplant recipients, HIV infected people, those on immunosuppressive drugs and newborns infected during pregnancy. Aim: To estimate the disease burden of Cytomegalovirus infection among the patients attending Rajendra Institute of Medical Sciences. Samples of clinically suspected cases of cytomegalovirus infection from all the age groups were collected and sent to the Department of Microbiology, RIMS, Ranchi, from January 2021 to December 2021. The samples were tested for IgM by ELISA. Results: During the study period, a total of 618 samples from clinically suspected cases were received for testing out of which, 67 samples tested positive. Of the total positive cases, 41 were males and 26 were females. Conclusion: Anti-CMV drugs are available now-a- days for the treatment of severe infections in immunosuppressed patients. Developments of vaccine to protect pregnant women from primary infection are in progress.